221 related articles for article (PubMed ID: 16620466)
1. Multiple sclerosis.
Ford H; Nicholas R
Clin Evid; 2005 Dec; (14):1637-51. PubMed ID: 16620466
[No Abstract] [Full Text] [Related]
2. Multiple sclerosis.
Boggild M; Ford H
Clin Evid; 2004 Dec; (12):1843-60. PubMed ID: 15865753
[No Abstract] [Full Text] [Related]
3. [Multiple sclerosis--recent advances in pathogenesis and treatment].
Itoyama Y; Fujihara K; Nakashima I; Misu T; Fujimori T; Sato S
No To Shinkei; 2002 Jan; 54(1):5-21. PubMed ID: 11868352
[No Abstract] [Full Text] [Related]
4. Multiple sclerosis.
Boggild M; Ford H
Clin Evid; 2003 Jun; (9):1459-73. PubMed ID: 15366193
[No Abstract] [Full Text] [Related]
5. [Multiple sclerosis].
Itoyama Y
No To Shinkei; 2000 Dec; 52(12):1051-5. PubMed ID: 11193536
[No Abstract] [Full Text] [Related]
6. Newer long-term treatments for multiple sclerosis.
Pryse-Phillips W
Clin Neurol Neurosurg; 2002 Jul; 104(3):265-71. PubMed ID: 12127666
[No Abstract] [Full Text] [Related]
7. [Will there soon be a sub-type specific treatment? New approaches to multiple sclerosis therapy].
MMW Fortschr Med; 2008 Apr; 150(15):17. PubMed ID: 18510111
[No Abstract] [Full Text] [Related]
8. [Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo].
Tedeholm H; Skoog B; Hillert J; Runmarker B; Stawiarz L; Oluf A
Lakartidningen; 2007 May 30-Jun 3; 104(22):1684-8. PubMed ID: 17601317
[No Abstract] [Full Text] [Related]
9. [Multiple sclerosis].
Ochi H; Kira J
Ryoikibetsu Shokogun Shirizu; 2000; (31):47-51. PubMed ID: 11269138
[No Abstract] [Full Text] [Related]
10. Alphabet soup: a personal, evolving, mostly evidence-based and logical, sequential approach to the "ABCNR" drugs in multiple sclerosis.
Mattson DH
Semin Neurol; 2002 Mar; 22(1):17-25. PubMed ID: 12170390
[TBL] [Abstract][Full Text] [Related]
11. [Multiple sclerosis--current status of therapy].
Reichel D; Kölmel HW
Z Arztl Fortbild (Jena); 1995 May; 89(2):151-8. PubMed ID: 7610682
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis trials.
Kappos L
Lancet; 1999 Jun; 353(9171):2242-3. PubMed ID: 10393009
[No Abstract] [Full Text] [Related]
13. How should we proceed with disease-modifying treatments for multiple sclerosis?
Andersson PB; Waubant E; Goodkin DE
Lancet; 1997 Mar; 349(9052):586-7. PubMed ID: 9057726
[No Abstract] [Full Text] [Related]
14. Combining two multiple sclerosis treatments has no clinical benefit, study finds.
Anekwe L
BMJ; 2013 Mar; 346():f1719. PubMed ID: 23491460
[No Abstract] [Full Text] [Related]
15. Multiple sclerosis: early management.
Zajicek J
Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):137-40. PubMed ID: 9166373
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis.
Boggild M; Ford H
Clin Evid; 2003 Dec; (10):1566-81. PubMed ID: 15555161
[No Abstract] [Full Text] [Related]
17. [Multiple sclerosis in children].
Neuteboom RF; Catsman-Berrevoets CE; Hintzen RQ
Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1464-8. PubMed ID: 17633977
[TBL] [Abstract][Full Text] [Related]
18. Patient and family fact sheet. Current treatments for multiple sclerosis.
Kernich CA
Neurologist; 2005 Mar; 11(2):137-8. PubMed ID: 15733335
[No Abstract] [Full Text] [Related]
19. New treatments and azathioprine in multiple sclerosis.
Kolar OJ
Lancet; 1997 Oct; 350(9083):1033. PubMed ID: 9329539
[No Abstract] [Full Text] [Related]
20. A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase.
Tourtellotte WW; Syndulko K; Baumhefner RW; Shapshak P; Osborne M
Neurology; 1988 Jul; 38(7 Suppl 2):83-6. PubMed ID: 3386848
[No Abstract] [Full Text] [Related]
[Next] [New Search]
